Trial · Interventional
CompletedPhase 1Registry dataA Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
Overview
- Status
- Completed
- Phase
- Phase 1
- Enrollment
- 30 participants (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Design
- Randomized · Open label (no masking)
- Countries
1 country
Germany
- Start
- 10 Feb 2025
- Primary completion
- 29 May 2025
- Completion
- 10 Jun 2025
- First posted
- 13 Jan 2025
- Last update posted
- 13 Mar 2026
- Conditions
- Healthy
Timeline
1 trial · 1 completed
- Completed
- Ongoing
- Not yet recruiting
- Stopped
- Estimated dates (est.)
- Results posted
- Ph 1
A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
NCT0677253210 Feb 2025 to 10 Jun 2025
Registry summary
Text and fields below are the sponsor's entries at ClinicalTrials.gov, shown as posted.
The main objective of this trial is to investigate relative bioavailability of BI 456906 formulation B and BI 456906 formulation C vs. BI 456906 formulation A.
Interventions
- BI 456906 - Formulation ACombination product
- BI 456906 - Formulation BDrug
- BI 456906 - Formulation CDrug
Arms3
Experimental
Treatment sequence R-T2-T1
T1: BI 456906 formulation B T2: BI 456906 formulation C R: BI 456906 formulation A
Experimental
Treatment sequence T1-R-T2
Experimental
Treatment sequence T2-T1-R
Primary outcomes2
Outcomes the sponsor listed as primary.
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz)
Time frame · Up to 22 days
Maximum measured concentration of the analyte in plasma (Cmax)
Time frame · Up to 22 days
Secondary outcomes(1)
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity (AUC0-∞)
Time frame · Up to 22 days
Posted results
Values are shown as posted at ClinicalTrials.gov, with their units. PepBank has not converted, pooled or compared them.
No results are posted for this trial.
Completed trials do not always post results.
Registry data comes from ClinicalTrials.gov. Study results come from studies, not from the registry. How PepBank works
Studies0
Studies that cite this trial.
No study cites this trial.
Eligibility
Who could join, as posted.
- Sex
- All
- Age
- from 18 Years up to 55 Years
- Healthy volunteers
- Accepted
Inclusion and exclusion criteria, as posted
PepBank is a research reference. Talk to a doctor before you use any peptide.